83 related articles for article (PubMed ID: 25816993)
1. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
[TBL] [Abstract][Full Text] [Related]
2. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
[TBL] [Abstract][Full Text] [Related]
3. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
4. Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients.
Pham A; Garai I; Árpád K; Dér Á; Szanto E; Hascsi Z; Bátyi F; Berényi E; Pham TM
Med Sci Monit; 2024 Jan; 30():e942122. PubMed ID: 38243589
[TBL] [Abstract][Full Text] [Related]
5. Detection of synchronous cancers by fluorodeoxyglucose positron emission tomography/computed tomography during primary staging workup for esophageal squamous cell carcinoma in Taiwan.
Chen SH; Chan SC; Chao YK; Yen TC
PLoS One; 2013; 8(11):e82812. PubMed ID: 24312435
[TBL] [Abstract][Full Text] [Related]
6. Detecting recurrent disease and surgical outcomes in patients with locally advanced tongue cancer after multimodal treatment using ¹⁸F-FDG-PET/CT.
Chen WL; Zhou B; Huang ZX; Dong XY; Chen R
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3):101673. PubMed ID: 37923135
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography.
Morbelli S; Conzi R; Campus C; Cittadini G; Bossert I; Massollo M; Fornarini G; Calamia I; Marini C; Fiz F; Ghersi C; Derchi LE; Sambuceti G
Cancer Imaging; 2014 Apr; 14(1):10. PubMed ID: 25609564
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients.
Hatzoglou V; Ulaner GA; Zhang Z; Beal K; Holodny AI; Young RJ
Clin Imaging; 2013; 37(3):451-7. PubMed ID: 23068052
[TBL] [Abstract][Full Text] [Related]
9. Quantitative
Ma W; Wang M; Li X; Huang H; Zhu Y; Song X; Dai D; Xu W
Oncol Lett; 2018 Oct; 16(4):4129-4136. PubMed ID: 30214552
[TBL] [Abstract][Full Text] [Related]
10. Impact of smoking on pathological features in oral cavity squamous cell carcinoma.
Al Feghali KA; Ghanem AI; Burmeister C; Chang SS; Ghanem T; Keller C; Siddiqui F
J Cancer Res Ther; 2019; 15(3):582-588. PubMed ID: 31169224
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers.
Jiménez-Sánchez J; Bosque JJ; Jiménez Londoño GA; Molina-García D; Martínez Á; Pérez-Beteta J; Ortega-Sabater C; Honguero Martínez AF; García Vicente AM; Calvo GF; Pérez-García VM
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536339
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.
Boellaard R; Delgado-Bolton R; Oyen WJ; Giammarile F; Tatsch K; Eschner W; Verzijlbergen FJ; Barrington SF; Pike LC; Weber WA; Stroobants S; Delbeke D; Donohoe KJ; Holbrook S; Graham MM; Testanera G; Hoekstra OS; Zijlstra J; Visser E; Hoekstra CJ; Pruim J; Willemsen A; Arends B; Kotzerke J; Bockisch A; Beyer T; Chiti A; Krause BJ;
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):328-54. PubMed ID: 25452219
[TBL] [Abstract][Full Text] [Related]
13. Radiographic imaging of human papillomavirus related carcinomas of the oropharynx.
Corey AS; Hudgins PA
Head Neck Pathol; 2012 Jul; 6 Suppl 1(Suppl 1):S25-40. PubMed ID: 22782221
[TBL] [Abstract][Full Text] [Related]
14. Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.
Cavanagh K; McLean LS; Lim AM; Cardin A; Levy SM; Rischin D
Cancer Imaging; 2024 Mar; 24(1):37. PubMed ID: 38500235
[TBL] [Abstract][Full Text] [Related]
15. Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease.
Kuker RA; Mesoloras G; Gulec SA
Int Semin Surg Oncol; 2007 Jul; 4():17. PubMed ID: 17623095
[TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography (PET) in Oncology.
Gallamini A; Zwarthoed C; Borra A
Cancers (Basel); 2014 Sep; 6(4):1821-89. PubMed ID: 25268160
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis.
Yap WK; Hsu KH; Wang TH; Lin CH; Kang CJ; Huang SM; Lin HC; Hung TM; Chang KP; Tsai TY
Ann Nucl Med; 2024 May; ():. PubMed ID: 38724805
[TBL] [Abstract][Full Text] [Related]
18. Use of Imaging in Cutaneous Squamous Cell Carcinoma to Detect High-Risk Tumor Features, Nodal Metastasis, and Distant Metastasis: A Systematic Review.
Libson K; Sheridan C; Carr DR; Shahwan KT
Dermatol Surg; 2024 Apr; ():. PubMed ID: 38624106
[TBL] [Abstract][Full Text] [Related]
19. Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives.
O'Connor JP; Jackson A; Asselin MC; Buckley DL; Parker GJ; Jayson GC
Lancet Oncol; 2008 Aug; 9(8):766-76. PubMed ID: 18672212
[TBL] [Abstract][Full Text] [Related]
20. Qualitative and quantitative spermatic cord abnormalities at CT predict symptomatic scrotal pathology.
Whitesell RT; Brunner JF; Collins HR; Sheafor DH
Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38517545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
